Effectiveness of Thoracic Facet Joint Nerve Blocks
1 other identifier
interventional
100
1 country
1
Brief Summary
- 1.To demonstrate whether:
- 2.To demonstrate whether or not there are clinically significant improvements in function of patients who receive thoracic facet joint nerve block with Depo-steroid compared to patients randomized to Group I who receive only local anesthetic blocks.
- 3.To determine the adverse event profile in both groups
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable low-back-pain
Started Aug 2003
Longer than P75 for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 24, 2006
CompletedFirst Posted
Study publicly available on registry
July 25, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedResults Posted
Study results publicly available
November 26, 2013
CompletedMarch 10, 2020
March 1, 2020
2.9 years
July 24, 2006
December 6, 2012
March 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Numeric Rating Scale
Numeric rating scale represented 0 with no pain and 10 with the worst pain imaginable.
2 years
Oswestry Disability Index
Oswestry Disability Index (ODI) - ODI score is ranged from 0 to 50. Total score is converted in to percent disability. ODI Scoring: 0% to 20% (minimal disability), 21%-40% (moderate disability), 41%-60% (severe disability), 61%-80% (crippled) and 81%-100 (these patients are either bed-bound or exaggerating their symptoms).
24 months
Other Outcomes (1)
Opioid Intake
24 months
Study Arms (2)
Group I - without Steroids
ACTIVE COMPARATORThoracic Facet Joint Nerve Blocks with Local Anesthetic(0.25% Bupivacaine)
Group II - with steroid
ACTIVE COMPARATORThoracic Facet Joint Nerve Blocks with Local Anesthetic (0.25% Bupivacaine) and Sterioids(0.15 mg of non-particulate betamethasone)
Interventions
Thoracic medial branch blocks
Eligibility Criteria
You may qualify if:
- Positive for facet joint pain with comparative local anesthetic blocks
- Candidates are over 18 years of age
- Subjects with a history of chronic, function limiting neck pain of at least six months in duration Subjects who are able to give voluntary, written informed consent to participate in this investigation Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the center for all the required post-operative follow-ups The subject has not had recent surgical procedures within the last three months.
You may not qualify if:
- Negative or false-positive response to controlled comparative local anesthetic blocks
- Narcotic use of greater than Hydrocodone 100 mg/day, Methadone 80 mg or Morphine 100 mg, or dose equivalent
- Uncontrolled major Depression or uncontrolled psychiatric disorders
- Uncontrolled or acute medical illnesses including coagulopathy, renal insufficiency, chronic liver dysfunction, progressive neurological deficit, urinary sphincter dysfunction, infection, increased intercranial pressure, pseudotumor cerebri, intercranial tumors, unstable angina, and severe chronic obstructive pulmonary disease.
- Chronic severe conditions that could interfere with the interpretations of the outcome assessments for pain and bodily function
- Women who are pregnant or lactating
- Subjects who have participated in a clinical study with an investigational product within 30 days of enrollment
- Patients with multiple complaints involving concomitant hip osteoarthritis, will not be amenable to study due to the overlap of pain complaints.
- Inability to achieve appropriate positioning and inability to understand informed consent and protocol History of adverse reaction to local anesthetic or anti-inflammatory drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ambulatory Surgery Center
Paducah, Kentucky, 42003, United States
Related Publications (3)
Manchikanti L, Singh V, Falco FJ, Cash KA, Pampati V, Fellows B. The role of thoracic medial branch blocks in managing chronic mid and upper back pain: a randomized, double-blind, active-control trial with a 2-year followup. Anesthesiol Res Pract. 2012;2012:585806. doi: 10.1155/2012/585806. Epub 2012 Jul 19.
PMID: 22851967RESULTManchikanti L, Singh V, Falco FJ, Cash KA, Pampati V, Fellows B. Comparative effectiveness of a one-year follow-up of thoracic medial branch blocks in management of chronic thoracic pain: a randomized, double-blind active controlled trial. Pain Physician. 2010 Nov-Dec;13(6):535-48.
PMID: 21102966DERIVEDManchikanti L, Singh V, Falco FJ, Cash KA, Pampati V. Effectiveness of thoracic medial branch blocks in managing chronic pain: a preliminary report of a randomized, double-blind controlled trial. Pain Physician. 2008 Jul-Aug;11(4):491-504.
PMID: 18690278DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Laxmaiah Manchikanti, MD
- Organization
- Pain Management Center of Paducah
Study Officials
- PRINCIPAL INVESTIGATOR
Laxmaiah Manchikanti, MD
Ambulatory Surgery Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Director
Study Record Dates
First Submitted
July 24, 2006
First Posted
July 25, 2006
Study Start
August 1, 2003
Primary Completion
July 1, 2006
Study Completion
July 1, 2011
Last Updated
March 10, 2020
Results First Posted
November 26, 2013
Record last verified: 2020-03